TOLEDO - NAMSA, a medical device testing and regulatory consulting firm, has acquired Labcorp’s (NYSE:LH) Early Development medical device testing business, according to a press release issued ...
Hosted on MSN
LH Q3 Deep Dive: Labcorp Sees Diagnostic Growth, Eyes Specialty Testing and Efficiency Initiatives
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q3 CY2025, with sales up 8.6% year on year to $3.56 billion. Its non-GAAP profit of $4.18 per share was 1% above analysts’ consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback